DOI: https://dx.doi.org/10.18565/urology.2018.3.98-104
П.В. Глыбочко, Ю.Г. Аляев, А.В. Амосов, Д.В. Еникеев, Д.В. Чинёнов, Г.Е. Крупинов, К.Б. Пузаков, А.В. Кошкарев, Ю.В. Лернер, Н.В. Петровский, З.К. Джалаев, Я.Н. Чернов
ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
1. Ferlay J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359. 2. Haas G.P. et al. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol. 2008;15:3866. 3. Kaprin A.D., Starinskii V.V., Petrova G.V. Malignant neoplasms in Russia in 2014. Morbidity and mortality. M.: FGBU MNIOI im. P.A. Gertsena Minzdrava Rossii. 2016; 250 p. Russian (Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2014 году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России. 2016. 250 с.). 4. Roobol M.J. et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol. 2010;57:79. 5. Hara R. et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. Urology. 2008;71:191. 6. Takenaka A. et al. A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy. Prostate Cancer Prostatic Dis. 2008;11:134. 7. Arsov C. et al. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol. 2015;68:713. 8. Walz J. et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol. 2006;50:498. 9. Moran B.J. et al. Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol. 2006;176:1376. 10. Wegelin O. et al. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique? Eur Urol. 2016. 11. Puech P. et al. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. Radiology. 2013;268:461. 12. Wysock J.S. et al. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol. 2014;66:343. 13. Каприн А.Д. и др. Возможности МРТ и ТРУЗИ fusion-навигации при биопсии предстательной железы. Диагностическая и интервенционная радиология. 2016;10(1):51–56. 14. Weinreb J.C., Barentsz J.O., Choyke P.L. et al. PI-RADS prostate imaging – reporting and data system: 2015, version 2. Eur Urol. 2016;69:16–40. 15. deRooij M., Hamoen E.H., Futterer J.J. et al. Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. AJR Am J Roentgenol. 2014;202:343–351. 16. Martorana E., Pirola G.M., Scialpi M. et al. Lesion volume predicts prostate cancer risk and aggressiveness: validation of its value alone and matched with prostate imaging reporting and data system score. BJU Int. 2017;120:92–103. 17. Abraham N.E., Mendhiratta N., Taneja S.S. Patterns of repeat prostate biopsy in contemporary clinical practice. J Urol. 2015;193:1178–1184. 18. Mendhiratta N., Meng X., Rosenkrantz A.B. et al. Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies. Urology. 2015;86:1192–1198. 19. Rosenkrantz A.B., Verma S., Choyke P. et al. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol. 2016;196:1613–1618. 20. Mendhiratta N., Rosenkrantz A.B., Meng X. et al. Magnetic resonance Imaging-Ultrasound fusion targeted prostate biopsy in a consecutive cohort of men with no previous biopsy: reduction of over detection through improved risk stratification. J Urol. 2015;194:1601–1606. 21. Meng X., Rosenkrantz A.B., Mendhiratta N. et al. Relationship between prebiopsymultiparametric magnetic resonance imaging (MRI), biopsy indication, and MRIultrasound fusion-targeted prostate biopsy outcomes. Eur Urol. 2016;69:512–517. 22. Tran G.N., Leapman M.S., Nguyen H.G. et al. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. Eur Urol 2016. (Epub ahead of print). 23. MIM Software Inc. 2016. Recommended Acquisition Protocols for Multiparametric MRI Imaging (mpMRI). www.mimsoftware.com.
А в т о р д л я с в я з и: А. В. Кошкарев – ординатор кафедры урологии ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия; e-mail: Koshkarevalexey@gmail.com